PIONEER POWER SOLUTIONS, INC. reported the fourth quarter ended December 31, 2025 results: revenue $5.6 million, net income $(1.4) million.
“Q4 2025 Financial Highlights ● Revenue was $5.6 million, compared to $9.8 million for the same quarter in 2024. ● Gross profit was $1.3 million, or a gross margin of 23.5%, as compared to $2.8 million, or a gross margin of 28.9%, for the same quarter in 2024. ● Operating loss was $(1.1) million, unchanged from $(1.1) million for the same quarter in 2024. ● Non–GAAP operating income* from continuing operations, which excludes corporate overhead expenses, research and development expenses, depreciation and amortization expenses and non-recurring professional fees, was $589,000, as compared to $1.9 million for the same quarter in 2024. ● Net loss was $(1.4) million, inclusive of loss from discontinued operations of $(17,500), as compared to net income of $36.3 million, inclusive of income from discontinued operations of $35.5 million, in the year ago quarter.”
NRIXNurix Therapeutics, Inc.
Nurix Therapeutics, Inc. reported the fiscal quarter ended February 28, 2026 results: revenue $6.3 million.
“Revenue for the three months ended February 28, 2026, was $6.3 million”
STZCONSTELLATION BRANDS, INC.
CONSTELLATION BRANDS, INC. reported Fourth quarter ended February 28, 2026 results: revenue $1,920 million, net income $202 million, EPS $1.16.
CONSTELLATION BRANDS, INC. reported Fiscal year ended February 28, 2026 results: revenue $9,139 million, net income $1,687 million, EPS $9.61.
“Fiscal 2026 Financial Highlights (1) | In millions, except per share data Reported $9,139 $9,139 $2,721 $1,687 $2,730 $9.61”
AXILAxil Brands, Inc.
Axil Brands, Inc. reported fourth quarter of fiscal 2026 results: revenue $8 million to $10 million. Guidance initiated.
“Fourth Quarter and Fiscal Year 2026 Outlook Based on our current visibility and assumptions regarding continued retail expansion and other factors, we expect revenue for the fourth quarter of fiscal 2026 to be in the range of $8 million to $10 million, representing approximately 39% to 74% year-over-year growth, with gross margins for the fourth quarter of fiscal 2026 to be”
AXILAxil Brands, Inc.
Axil Brands, Inc. reported third fiscal quarter ended February 28, 2026 results: revenue $7.3 million, net income $0.2 million, EPS $0.02 per diluted share.
“results for the third fiscal quarter ended February 28, 2026 (“Q3 2026”). Financial Highlights for the Quarter Ended February 28, 2026 · Net sales increased 5.4% in Q3 2026 to $7.3 million, compared to $6.9 million in the prior year period · Gross profit was largely unchanged at approximately $5.0 million for both periods, representing 69.1% gross margin in Q3”
GLTKGlobalTech Corp
GlobalTech Corp reported the year ended December 31, 2025 results: revenue $22.1 million, net income $(3.1) million.
“as previously reported in its Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission on March 31, 2026. Fiscal Year 2025 Highlights · Net Revenue: $22.1 million, up 21% from $18.3 million in 2024 · Operating Loss: $(3.7) million · Net Loss: $(3.1) million · Adjusted EBITDA: $0.89 million (non-GAAP)* · Total Assets: $103.1 million · Total”
INFQInfleqtion, Inc.
Infleqtion, Inc. reported 2026 results: revenue $40 million. Guidance initiated.
“Infleqtion Announces 2026 Revenue Guidance of $40 Million”
INFQInfleqtion, Inc.
Infleqtion, Inc. reported the year ended December 31, 2025 results: revenue $32.5 million.
“For Full Year Ending December 31, 2025 1 : • Revenue of $32.5 million.”
DALDELTA AIR LINES, INC.
DELTA AIR LINES, INC. updated its the quarter ended March 31, 2026 guidance (reaffirmed).
“Delta Air Lines, Inc. today issued a press release reporting financial results for the quarter ended March 31, 2026.”
TOMZTOMI Environmental Solutions, Inc.
TOMI Environmental Solutions, Inc. reported first quarter of 2026 results: revenue $1.7 million.
“its preliminary unaudited revenue for the first quarter of 2026 was approximately $1.7 million”
RELLRICHARDSON ELECTRONICS, LTD.
RICHARDSON ELECTRONICS, LTD. reported third quarter ended February 28, 2026 results: revenue $55.5 million, net income $0.9 million, EPS $0.07 per diluted share.
“to drive continued growth and deliver long-term value for our shareholders,” Mr. Richardson concluded. Third Quarter Results Net sales for the third quarter of fiscal 2026 were $55.5 million, a 3.1% increase from $53.8 million in the prior year’s third quarter. When excluding Healthcare, net sales increased 6.0% year-over-year. Year-over-year net sales growth was due”
“For the fourth quarter alone, total revenue was $26.2 million, a decrease of 8.1% from $28.5 million in the same period last year.”
VIRCVIRCO MFG CORPORATION
VIRCO MFG CORPORATION reported fourth quarter and fiscal year ended January 31, 2026 results: revenue $199.7 million, net income $2.6 million.
“For the full fiscal year ended January 31, 2026, net income was $2.6 million on total revenue of $199.7 million.”
ICCCIMMUCELL CORP /DE/
IMMUCELL CORP /DE/ reported the quarter ended March 31, 2026 results: revenue $10.4 million.
“health and productivity, today announced preliminary, unaudited sales results for the first quarter of 2026. Total sales for the three-month period ended March 31, 2026 were $10.4 million, a 28.4% increase compared to the three-month period ended March 31, 2025. For the three-month period ended March 31: ● Domestic sales were $9.7 million in 2026, a 35.7% increase”
CHSCPCHS INC
CHS INC reported second quarter of fiscal year 2026 ended February 28, 2026 results: revenue $8.4 billion, net income $147.1 million.
“CHS Inc., a global agribusiness and the nation’s leading cooperative, today released results for its second quarter of fiscal year 2026. The company reported a net loss of $147.1 million and revenues of $8.4 billion for the quarter that ended February 28, 2026, compared to a net loss of $75.8 million and revenues of $7.8 billion in the second quarter of fiscal year 2025.”
REGNREGENERON PHARMACEUTICALS, INC.
REGENERON PHARMACEUTICALS, INC. reported preliminary financial results for first quarter 2026.
“Regeneron Pharmaceuticals, Inc. (“ Regeneron ” or the “ Company ”) currently expects that its financial results calculated in accordance with U.S. generally accepted accounting principles (“ GAAP ”) and its non-GAAP financial results for the first quarter 2026 will include an acquired in-process research and development (“ IPR&D ”) charge of approximately $102 million on a pre-tax basis.”
GBRNew Concept Energy, Inc.
New Concept Energy, Inc. reported the quarter ended December 31, 2025 results: revenue $103,000, net income $12,000.
“$46,000 compared to a net loss of $18,000 for the same period ended December 31, 2043. Fiscal 2025 as compared to 2024 Revenues: Revenues from rent for the leased property was $103,000 in 2025 and $101,000 in 2024. Revenues from managing the oil and gas operations for a third party was $52,000 and $45,000 in 2025 and 2024. The management agreement has the”
GRUSFGrown Rogue International Inc.
Grown Rogue International Inc. reported Q4 2025 results: revenue $8.8 million, net income ($2.1) million. Guidance initiated.
“Revenue for Q4 2025 was $8.8 million and GAAP net loss was ($2.1) million and Adjusted EBITDA (non-GAAP) was $1.2 million (13.4% margin).”
GRUSFGrown Rogue International Inc.
Grown Rogue International Inc. reported the year ended December 31, 2025 results: revenue $32.4 million, net income $3.2 million. Guidance initiated.
“Revenue of $32.4 million for the full year 2025, up 22% from $26.6 million in 2024, with growth driven by the late-2024 entry into the New Jersey market, partly offset by the termination of the Vireo consulting agreement in September of 2024 and substantial pricing pressure that contributed to revenue declines of 22% in Michigan and 8% in Oregon. • Adjusted EBITDA (non-GAAP) of $5.4 million (16.5% margin) for 2025, up 42% from $3.8 million in 2024, with contributions from New Jersey partly offset by pricing pressure in Michigan and Oregon and higher corporate overhead associated with growth initiatives. • GAAP net income of $3.2 million for 2025, including a non-cash gain of approximately $5.9 million related to the fair value of derivative liabilities.”
SSSSSURO CAPITAL CORP.
SURO CAPITAL CORP. reported preliminary financial results for the first quarter ended March 31, 2026.
“On April 7, 2026, SuRo Capital Corp. (“SuRo Capital” or the “Company”) issued a press release containing preliminary estimates of its results for the first quarter ended March 31, 2026 (the “Press Release”).”
SMXTSolarMax Technology, Inc.
SolarMax Technology, Inc. reported the fiscal year ended December 31, 2025 results: revenue $91.0 million, net income Net loss: $35.0 million, EPS $0.79 per share.
“or the “Company”), an integrated solar energy company, reported financial results for the fiscal year ended December 31, 2025. Fiscal Year 2025 Financial Highlights · Revenue: $91.0 million, up 296% from $23.0 million in 2024. · Gross profit: $4.2 million, up 83% from $2.3 million in 2024. · Total operating expense: $10.5 million, a $24.9 million reduction from”
JAGXJaguar Health, Inc.
Jaguar Health, Inc. reported year ended December 31, 2025 results: revenue $11.5 million, net income $53.6 million net loss, EPS ($24.27) per share.
“the total net revenue in the fourth quarter of 2024, which totaled approximately $3.5 million. • In 2025, approximately $11.2 million out of the Company’s total net revenue of $11.5 million was generated by sales of Mytesi and Canalevia-CA1. Under the terms of the license agreement Jaguar entered with Future Pak (“FP”) in January 2026, FP will be responsible for all”
PXEDPhoenix Education Partners, Inc.
Phoenix Education Partners, Inc. reported second quarter fiscal year 2026 (three months ended February 28, 2026) results: revenue $222.5 million, net income $10.8 million, EPS $0.28 diluted earnings per share.
“company of The University of Phoenix, Inc. (the “University”), today reported financial results for the three months ended February 28, 2026, with second quarter revenue of $222.5 million. “At the University, we remain focused on helping students develop skills that translate directly into their careers. We are proud to have issued more than one million digital”
KRUSKURA SUSHI USA, INC.
KURA SUSHI USA, INC. reported fiscal second quarter ended February 28, 2026 results: revenue $80.0 million, net income Net loss was $1.7 million, or $(0.14) per diluted share, EPS $(0.14) per diluted share.
“Kura Sushi USA Announces Fiscal Second Quarter 2026 Financial Results Irvine, CA. April 7, 2026 – Kura Sushi USA, Inc. (“Kura Sushi” or the “Company”) (NASDAQ: KRUS), a technology-enabled Japanese restaurant concept, today announced financial results for the fiscal second quarter ended February 28, 2026. Fiscal Second Quarter 2026 Highlights ➢ Total sales were $80.0 million, compared to $64.9 million in the second quarter of 2025; ➢ Comparable restaurant sales increased 8.6% for the second quarter of 2026 as compared to the second quarter of 2025; ➢ Operating loss was $2.2 million, compared to an operating loss of $4.6 million in the second quarter of 2025; ➢ Net loss was $1.7 million, or $(0.14) per diluted share, compared to net loss of $3.8 million, or $(0.31) per diluted share, in the second quarter of 2025”
SKILSkillsoft Corp.
Skillsoft Corp. reported fiscal year ended January 31, 2026 results: revenue Total Revenue of $513 million, net income Net Loss of $140 million, EPS Net Loss per share of $16.27.
“Fiscal 2026 Full Year Select Financial Measures ● Total Revenue of $513 million compared to $531 million in the prior year. ● Talent Development Solutions Revenue of $404 million compared to $406 million in the prior year. ● Global Knowledge Revenue of $109 million compared to $125 million in the prior year. ● Net Loss of $140 million compared to Net Loss of $122 million in the prior year. Net Loss per share of $16.27 compared to Net Loss per share of $14.87 in the prior year.”
SKILSkillsoft Corp.
Skillsoft Corp. reported Q4 fiscal year ended January 31, 2026 results: revenue Total Revenue of $131 million, net income Net Loss of $37 million, EPS Net Loss per share of $4.19.
“Skillsoft Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2026 ● TDS Segment (1) delivered full year revenue in line with guidance, with TDS Segment Adjusted EBITDA and consolidated Free Cash Flow above the top end guidance ● Next-generation Skillsoft Percipio® Platform generally available, with 15 new customers since release ● Early adopters accelerating utilization of our AI tools BOSTON – April 7, 2026 – Skillsoft Corp. (NYSE: SKIL) (“Skillsoft”, “we”, “us” or “our”), a global leader in skills management for the human + AI era, today announced its financial results for the fourth quarter and full fiscal year ended January 31, 2026 and provided its TDS Segment financial outlook for full year fiscal 2027. Fiscal 2026 Fourth Quarter Select Financial Measures ● Total Revenue of $131 million compared to $134 million in the prior year. ● Talent Development Solutions Revenue of $103 million, flat versus the prior year. ● Global Knowledge Revenue of $28 million comp”
GPUSHyperscale Data, Inc.
Hyperscale Data, Inc. reported the first quarter ended March 31, 2026 results: revenue in the range of approximately $43 million to $45 million.
“The Company expects to report consolidated revenue in the range of approximately $43 million to $45 million for the first quarter of 2026, representing an increase of approximately 72% to 80% compared to revenue of approximately $25.0 million for the first quarter of 2025.”
GBXGREENBRIER COMPANIES INC
GREENBRIER COMPANIES INC reported second fiscal quarter ended February 28, 2026 results: revenue $587.5M, net income $15 million, EPS $0.47 per diluted share. Guidance lowered.
“1,500 units of deliveries associated with Brazil. (2) Earnings from operations divided by revenue. Financial Summary Q2 FY26 Q1 FY26 Sequential Comparison – Main Drivers Revenue $587.5M $706.1M Primarily fewer deliveries Aggregate gross margin $69.5M $103.3M Lower production rates, timing of syndication deliveries, and planned facility shutdowns impacted”
LEVILEVI STRAUSS & CO
LEVI STRAUSS & CO reported the first quarter ended March 1, 2026 results: revenue $1.7 billion, net income $177 million, EPS $0.45. Guidance raised.
“to raise our full-year sales, margins and EPS guidance even as we remain prudent about the external environment.” Financial Highlights for the First Quarter • Net Revenues of $1.7 billion increased 14% on a reported basis and 9% on an organic basis versus Q1 2025. • In the Americas , net revenues increased 9% on a reported basis and increased 7% on an organic”
GBDCGOLUB CAPITAL BDC, Inc.
GOLUB CAPITAL BDC, Inc. reported financial results for the quarter ended March 31, 2026.
“On April 6, 2026, Golub Capital BDC, Inc. issued a press release announcing that it will release its financial results for the quarter ended March 31, 2026 on Monday, May 4, 2026 after the close of the financial markets.”
CIONCION Investment Corp
CION Investment Corp reported financial results for first quarter ended March 31, 2026.
“On April 6, 2026, CĪON Investment Corporation ("CION") issued a press release announcing that it will (i) report its financial results for the first quarter ended March 31, 2026 on Thursday, May 7, 2026, prior to the opening of the financial markets, and (ii) discuss those financial results in an earnings conference call at 11 a.m. Eastern Time that same day.”
PSXPhillips 66
Phillips 66 updated its first-quarter 2026 guidance (initiated).
“On April 6, 2026, Phillips 66 (the “Company”) issued guidance providing preliminary first-quarter 2026 financial information.”
AIRSAirsculpt Technologies, Inc.
Airsculpt Technologies, Inc. reported full year 2026 results: revenue $151 to $157 million. Guidance initiated.
“The Company projects full year 2026 revenue and adjusted EBITDA guidance as follows: • Revenue of approximately $151 to $157 million • Adjusted EBITDA of approximately $15 to $17 million”
AIRSAirsculpt Technologies, Inc.
Airsculpt Technologies, Inc. reported fourth quarter and twelve months ended December 31, 2025 results: revenue $33.4 million, net income $1.3 million. Guidance reaffirmed.
“• Case volume was 2,604 for the fourth quarter of 2025, representing a 15.0% decline from the fiscal year 2024 fourth quarter case volume of 3,064; • Revenue declined 14.6% to $33.4 million from $39.2 million in the fiscal year 2024 fourth quarter; • Net loss for the quarter was $1.3 million compared to net loss of $5.0 million in the fiscal year 2024 fourth”
BIIBBIOGEN INC.
BIOGEN INC. reported preliminary financial results for the first quarter of 2026.
“Biogen Inc. (Biogen) expects that its GAAP and non-GAAP results for the first quarter of 2026 will include acquired in-process research and development, upfront and milestone expense of approximately $34 million on a pre-tax basis.”
PHRPhreesia, Inc.
Phreesia, Inc. reported financial results for fiscal fourth quarter and fiscal year ended January 31, 2026.
“On March 30, 2026, Phreesia, Inc. (the “Company”) held a conference call to discuss its financial results for the fiscal fourth quarter and fiscal year ended January 31, 2026.”
ABBVAbbVie Inc.
AbbVie Inc. reported full-year ended December 31, 2026 results: EPS $13.96 - $14.16. Guidance lowered.
“AbbVie’s full-year 2026 adjusted diluted earnings per share guidance range, including the impact of first quarter 2026 acquired IPR&D and milestones expense, is $13.96 - $14.16.”
ABBVAbbVie Inc.
AbbVie Inc. reported quarter ended March 31, 2026 results: EPS $2.56 - $2.60. Guidance lowered.
“AbbVie’s first quarter 2026 adjusted diluted earnings per share guidance range, including the impact of first quarter 2026 acquired IPR&D and milestones expense, is $2.56 - $2.60.”
BTBDBT Brands, Inc.
BT Brands, Inc. reported fiscal year ended December 28, 2025 results: revenue $ 13,486,629, net income $ (687,839 ), EPS $ (0.11 ).
“BT BRANDS, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF OPERATIONS (52 Weeks Ended) 52 Weeks Ended, 52 Weeks Ended, December 28, 2025 December 29, 2024 SALES $ 13,486,629 $ 14,823,472 COSTS AND EXPENSES Food and paper costs 4,494,449 5,605,579 Labor costs 5,111,097 6,128,574 Occupancy costs 1,282,049 1,403,204 Other operating expenses 878,125 962,287 Depreciation and amortization 648,704 742,860 Impairment of restaurant and right-of-use assets 215,000 371,872 General and administrative 1,464,021 1,691,404 Gain on sale of assets (242,231 ) (250,000 ) Total costs and expenses 13,851,214 16,655,780 Loss from operations (364,585 ) (1,832,308 ) Unrealized gain (loss) on marketable securities 128,822 (93,458 ) Realized gain on marketable securities 380,764 143,340 Interest and dividend income 148,666 178,279 Interest expense (81,621 ) (99,608 ) Related party impairments and other charges (520,718 ) - Other income (74,728 ) 13,930 Equity in loss of unconsolidated affiliate (304,439 ) (415”
LCIDLucid Group, Inc.
Lucid Group, Inc. updated its the quarter ended March 31, 2026 guidance (reaffirmed).
“On April 3, 2026, Lucid Group, Inc. issued a press release announcing its production and delivery totals for the quarter ended March 31, 2026.”
ASFHASIAFIN HOLDINGS CORP.
ASIAFIN HOLDINGS CORP. reported the year ended December 31, 2025 results: revenue approximately $5.126 million, net income approximately $120,000.
“Financial Results for the Year Ended December 31, 2025: ● Net cash flow from operations was approximately $504,000 for the year ended December 31, 2025, compared to approximately $24,000 for the year ended December 31, 2024. ● Cash and cash equivalents were approximately $1.748 million as of December 31, 2025, compared to approximately $1.31 million as of December 31, 2024. ● Revenue for the years ended December 31, 2025 and 2024 was approximately $5.126 million and $3.382 million, respectively. This represents a growth of 51.5% in year 2025 compared to year 2024. ● Gross profit for the year ended December 31, 2025 was approximately $1.904 million, representing 37.14% of revenue, and for year ended December 31, 2024 was $1.424 million representing 42.09% of revenue. ● Selling, general and administrative expenses for the years ended December 31, 2025 and 2024 were approximately $1.874 million and $1.464 million, respectively. ● Net loss was approximately $120,000 for the yea”
NTHINEONC TECHNOLOGIES HOLDINGS, INC.
NEONC TECHNOLOGIES HOLDINGS, INC. reported the quarter and year ended December 31, 2025 results: net income $62.1 million or $3.20 per diluted share, EPS $3.20 per diluted share.
“$3,045k in Q4 2024, driven by active management of NEO100 trial sites, recruitment for NEO212, initiation of NEO100-3, and overall patient recruitment activity. ● Net loss: $62.1 million or $3.20 per diluted share, compared to $11.9 million or $0.69 per diluted share in Q4 2024, primarily due to increased general and administrative expenses, as well as”
RCMTRCM TECHNOLOGIES, INC.
RCM TECHNOLOGIES, INC. reported fifty-three weeks ended January 3, 2026 results: revenue $319.4 million, net income $16.3 million, or $2.14 per diluted share, EPS $2.14 per diluted share.
“RCM Technologies reported revenue of $319.4 million for the fifty-three weeks ended January 3, 2026 (the current year), an increase of 14.7% compared to $278.4 million for the fifty-two weeks ended December 28, 2024 (the comparable prior year). Gross profit was $87.9 million for the current year, a 10.2% increase compared to $79.8 million for the comparable prior year. The Company reported GAAP net income of $16.3 million, or $2.14 per diluted share, for the current year compared to $13.3 million, or $1.68 per diluted share, for the comparable prior year.”
RCMTRCM TECHNOLOGIES, INC.
RCM TECHNOLOGIES, INC. reported fourteen weeks ended January 3, 2026 results: revenue $86.5 million, net income $6.1 million, or $0.80 per diluted share, EPS $0.80 per diluted share.
“RCM Technologies reported revenue of $86.5 million for the fourteen weeks ended January 3, 2026 (the current quarter), an increase of 12.4% compared to $76.9 million for the thirteen weeks ended December 28, 2024 (the comparable prior quarter). Gross profit was $24.3 million for the current quarter, a 12.6% increase compared to $21.6 million for the comparable prior quarter. The Company reported GAAP net income of $6.1 million, or $0.80 per diluted share, for the current quarter, compared with $2.9 million, or $0.37 per diluted share, for the comparable prior quarter.”
EACOEACO CORP
EACO CORP reported the quarter ended February 28, 2026 results: revenue $ 117,836, net income $ 9,797, EPS $ 2.01.
“EACO CORPORATION REPORTS RECORD 2 nd QUARTER NET SALES AND ALL-TIME RECORD QUARTERLY NET INCOME ANAHEIM, CALIFORNIA April 2, 2026 – EACO Corporation (OTCID:EACO) announced the results for its quarter ended February 28, 2026. Net sales, net income and earnings per share were as follows for the quarter ended February 28, 2026 (dollars in thousands, except per share information): Three Months Ended February 28, % 2026 2025 Change (unaudited) (unaudited) Net sales $ 117,836 $ 100,132 17.7 % Net income $ 9,797 $ 6,763 44.9 % Basic earnings per common share $ 2.01 $ 1.39 44.6 %”
AUMNGolden Minerals Co
Golden Minerals Co reported the fiscal year ended December 31, 2025 results: net income Net income was $2.7 million, or $0.18 per basic share and $0.16 per diluted share, in 2025, EPS $0.18 per basic share and $0.16 per diluted share.
“Net income was $2.7 million, or $0.18 per basic share and $0.16 per diluted share, in 2025”
AYIACUITY INC. (DE)
ACUITY INC. (DE) reported the second quarter, ended February 28, 2026 results: EPS Diluted earnings per share was $3.09.
“Acuity Reports Fiscal 2026 Second-Quarter Results Strong Execution Delivers Sales Growth, Margin Expansion and EPS Improvement ■ Delivered Net Sales of $1.1B, an Increase of 5% Compared to the Prior Year ■ Delivered Operating Profit of $133M, Up 21% Compared to the Prior Year; Grew Adjusted Operating Profit to $176M, Up 8% Compared to the Prior Year ■ Delivered Diluted EPS of $3.09, Up 26% Compared to the Prior Year; Grew Adjusted Diluted EPS to $4.14, Up 11% Compared to the Prior Year”
ANGOANGIODYNAMICS INC
ANGIODYNAMICS INC reported third quarter of fiscal year 2026 ended February 28, 2026 results: revenue $78.4 million. Guidance raised.
“the third quarter of fiscal year 2026, which ended February 28, 2026. Fiscal Year 2026 Third Quarter Highlights Quarter Ended February 28, 2026 Pro Forma* YoY Growth Net Sales $78.4 million 8.9% Med Tech Net Sales $37.3 million 19.0% Med Device Net Sales $41.1 million 1.1% • GAAP gross margin of 52.9% • GAAP loss per share of $0.19 • Adjusted loss per share of $0.07”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.